Sponsored By

A patent pending technology that enables the production of catheters that are both radiopaque and translucent to the naked eye was introduced by NEU Specialty Engineered Materials LLC, a subsidiary of PolyOne Corp., at the MD&M West show this week in Anaheim, CA.

PlasticsToday Staff

February 13, 2014

1 Min Read
Catheter technology combines radiopacity and transparency

A patent pending technology that enables the production of catheters that are both radiopaque and translucent to the naked eye was introduced by NEU Specialty Engineered Materials LLC, a subsidiary of PolyOne Corp., at the MD&M West show this week in Anaheim, CA.

NEU-View-for-Catheters-250.jpgNEU View Radiopaque Translucent Solutions produces optically translucent catheters with superior contrast under X-ray compared with striped catheters, according to the company. The technology also reportedly boosts productivity by eliminating the coextrusion process used to manufacture striped catheters. Material usage and scrap rates also are reduced.

Benefits of the technology include visual confirmation of fluid flow, detection of potentially harmful air bubbles to prevent embolisms, and the use of a single catheter for both IV and X-ray procedures, resulting in fewer needle sticks.

NEU View formulations for cardiovascular and intravascular catheters are application-specific, incorporating medical-grade polymers, additives, color, and medical manufacturing practices. They are available in certified USP Class VI and ISO 10993 compositions.

Sign up for the PlasticsToday NewsFeed newsletter.

You May Also Like